Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fasiglifam + Sitagliptin in T2DM
NCT01829464Phase 3Terminated
- Sponsor
- Takeda
- Start
- May 2013
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of fasiglifam in type 2 diabetes mellitus (T2DM), sponsored by Takeda. Started May 2013; status: terminated.
02
Drugs
fasiglifam
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01829464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01829464.